CAN-104

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameCAN-104
Drug Alias NameCAN-104
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase stimulantsEnzyme replacements
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Biologics (Shanghai) Co LtdCANbridge (Shanghai) Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Biologics (Shanghai) Co LtdCANbridge (Shanghai) Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A